research Tumor Necrosis Factor in Sepsis
Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.
Search
for
Sort by
Research
120-150 / 1000+ results 
research Alpha-1 Adrenergic Receptor Agonist Induced Piloerection Protects Against the Development of Traction Alopecia
Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.
research Trichodynia: An Update on Definition, Etiopathogenesis, Diagnosis, and Treatment
Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.
research Alpha-1 Adrenergic Receptor Agonist Induced Piloerection Protects Against the Development of Traction Alopecia
Phenylephrine may help prevent hair loss from pulling on the hair roots.
research Side Effects of Topical Ophthalmic Beta-Blockers: Association with Alopecia
Eye drops with β-blockers may cause hair loss.
research Systematic Approach to Hair Loss in Women
A systematic approach is crucial for managing hair loss in women.
research Alopecia Possibly Secondary to Topical Ophthalmic Beta-Blockers
Topical eye β-blockers may cause hair loss.
research Color-Transition Sign: A Useful Trichoscopic Finding for Differentiating Alopecia Areata Incognita from Telogen Effluvium
The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.
research Telogen Effluvium: A Review of Acute and Chronic Forms
Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
research Alopecias
Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.
research Evaluation of Hair Loss
The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.
research Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients
More atypical club hairs may indicate Telogen Effluvium.
research Histopathologic Evaluation of Alopecias
The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.
research Female Pattern Hair Loss
Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.
research Effectiveness of Platelet-Rich Plasma in Treating Female Hair Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
PRP is an effective and safe treatment for female hair loss.
research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research Clinical Profile of Female Patients With Chronic Telogen Effluvium and Its Association With Serum Ferritin Level
Low iron levels may be linked to hair loss in women with chronic telogen effluvium.
research Telogen Effluvium: Exploring the Intersection of Dermatology, Psychology, and Public Health
Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.
research Reduced Ferritin, Folate, and Vitamin B12 Levels in Female Patients Diagnosed With Telogen Effluvium
Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.
research Estimation of Serum Ferritin Level in Female Patients with Telogen Effluvium
Low serum ferritin levels are not closely linked to telogen effluvium in women.
research Post-COVID Telogen Effluvium: The Diagnostic Value of Serum Ferritin Biomarker and the Preventive Value of Dietary Supplements. A Case-Control Study
Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.
research Alopecia Areata: A Comprehensive Review of Pathogenesis and Management
New treatments for Alopecia Areata show promise but need to be more effective and affordable.
research Prolactin: An Emerging Force Along the Cutaneous–Endocrine Axis
Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.
research Alopecias in Lupus Erythematosus
Different types of hair loss in lupus need careful diagnosis for proper treatment.
research The Role of Vitamin D in Non-Scarring Alopecia
Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.
research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients
COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.
research Prevalence and Factors Associated with Telogen Effluvium in Adult Females at Makkah Region, Saudi Arabia: A Retrospective Study
Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.
research Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey Among Dermatologists in Saudi Arabia
Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.
research Hair Casts
Hair casts may be caused by repetitive hair pulling or styling and are often misdiagnosed.
research Vitamin D Receptor Gene Polymorphism in Chronic Telogen Effluvium: A Case-Control Study
Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.